An Institutional Review Board (IRB) is a committee charged with protecting the rights and welfare of people participating in research activities. The IRB reviews and approves research applications involving human subjects, provides ongoing oversight to ensure regulatory compliance, and assures that the risks to research subjects are minimized and participation by these subjects is done so on a voluntary, informed basis.
Both the Food and Drug Administration and the Office for Human Research Protections provide guidelines and regulations governing human subjects research and establish the authority granted to the IRB. The IRB highly encourages all investigators, coordinators, sponsors and research volunteers to contact the IRB for questions, advice or concerns at any time. Any questions, concerns or suggestions will be responded to in a confidential and professional manner.
It's important to note that all research conducted at Mercy Gilbert Medical Center and Dignity Health must be reviewed by a Dignity Health IRB and facility administration.
For additional information, please call the East Valley Regional IRB at (480) 728-3582.
Research Study Looks at Adult Stem Cell Therapy for Heart Disease and Stroke
Nabil Dib, M.D., M.Sc., F.A.C.C., director of Cardiovascular Research at Chandler Regional and Mercy Gilbert Medical Centers, and Jonathan Hodgson, D.O., medical director of Mercy Gilbert Medical Center's Stroke Center, provided an overview of their research study to assess the efficacy of adult stem cell therapy for heart disease and stroke. Click here to watch their interview.
Dignity Health HRPO | Dignity Health IRB Locations | Compliance Hotline | Frequently Asked Questions